
### [MONDO:0015489](http://purl.obolibrary.org/obo/MONDO_0015489)
**Label:** predominantly medium-vessel vasculitis

**Subclasses:** [MONDO:0012727](http://purl.obolibrary.org/obo/MONDO_0012727) (mucocutaneous lymph node syndrome), [MONDO:0015374](http://purl.obolibrary.org/obo/MONDO_0015374) (primary central nervous system vasculitis), [MONDO:0008889](http://purl.obolibrary.org/obo/MONDO_0008889) (thromboangiitis obliterans), [MONDO:0014306](http://purl.obolibrary.org/obo/MONDO_0014306) (vasculitis due to ADA2 deficiency), 

**Mapped go classes:** [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0008440](http://purl.obolibrary.org/obo/GO_0008440) (inositol-1,4,5-trisphosphate 3-kinase activity), [GO:0016607](http://purl.obolibrary.org/obo/GO_0016607) (nuclear speck), [GO:0043103](http://purl.obolibrary.org/obo/GO_0043103) (hypoxanthine salvage), [GO:0004000](http://purl.obolibrary.org/obo/GO_0004000) (adenosine deaminase activity), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0043394](http://purl.obolibrary.org/obo/GO_0043394) (proteoglycan binding), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0030223](http://purl.obolibrary.org/obo/GO_0030223) (neutrophil differentiation), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0046103](http://purl.obolibrary.org/obo/GO_0046103) (inosine biosynthetic process), [GO:0006154](http://purl.obolibrary.org/obo/GO_0006154) (adenosine catabolic process), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0032958](http://purl.obolibrary.org/obo/GO_0032958) (inositol phosphate biosynthetic process), [GO:0005516](http://purl.obolibrary.org/obo/GO_0005516) (calmodulin binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0060837](http://purl.obolibrary.org/obo/GO_0060837) (blood vessel endothelial cell differentiation), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0031685](http://purl.obolibrary.org/obo/GO_0031685) (adenosine receptor binding), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0019239](http://purl.obolibrary.org/obo/GO_0019239) (deaminase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- [GO:0051766](http://purl.obolibrary.org/obo/GO_0051766) (inositol trisphosphate kinase activity) 55.56%
- [GO:0046101](http://purl.obolibrary.org/obo/GO_0046101) (hypoxanthine biosynthetic process) 55.56%
- [GO:0043103](http://purl.obolibrary.org/obo/GO_0043103) (hypoxanthine salvage) 55.56%
- [GO:0008440](http://purl.obolibrary.org/obo/GO_0008440) (inositol-1,4,5-trisphosphate 3-kinase activity) 55.56%
- [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding) 55.56%
- [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity) 55.56%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 55.56%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 55.56%
- [GO:0005516](http://purl.obolibrary.org/obo/GO_0005516) (calmodulin binding) 55.56%
- [GO:0046100](http://purl.obolibrary.org/obo/GO_0046100) (hypoxanthine metabolic process) and [GO:1901576](http://purl.obolibrary.org/obo/GO_1901576) (organic substance biosynthetic process) 55.56%
- [GO:0046100](http://purl.obolibrary.org/obo/GO_0046100) (hypoxanthine metabolic process) and [GO:1901566](http://purl.obolibrary.org/obo/GO_1901566) (organonitrogen compound biosynthetic process) 55.56%
- [GO:0046100](http://purl.obolibrary.org/obo/GO_0046100) (hypoxanthine metabolic process) and [GO:1901362](http://purl.obolibrary.org/obo/GO_1901362) (organic cyclic compound biosynthetic process) 55.56%
- [GO:0046100](http://purl.obolibrary.org/obo/GO_0046100) (hypoxanthine metabolic process) and [GO:0072522](http://purl.obolibrary.org/obo/GO_0072522) (purine-containing compound biosynthetic process) 55.56%
- [GO:0046100](http://purl.obolibrary.org/obo/GO_0046100) (hypoxanthine metabolic process) and [GO:0046148](http://purl.obolibrary.org/obo/GO_0046148) (pigment biosynthetic process) 55.56%
- [GO:0046100](http://purl.obolibrary.org/obo/GO_0046100) (hypoxanthine metabolic process) and [GO:0046112](http://purl.obolibrary.org/obo/GO_0046112) (nucleobase biosynthetic process) 55.56%


